Schedule 13G/A

UTMD Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 204.4K shares, representing 5.6% of UTAH MEDICAL PRODUCTS INC in this filing.

FiledJan 29, 2024

Ownership dateDec 31, 2023

Reported shares204.4K

Reported ownership5.6%

Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 204.4K

Shared voting power 204.4K

Sole dispositive power 204.4K

Shared dispositive power 204.4K

Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date—

Latest tracked price$71.21as of Aug 5, 2026

Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer: BlackRock
CIK: CIK0001364742
Accession: 0001086364-24-005552
Form: Schedule 13G/A

Open SEC filing View UTMD ownership history

Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →